skip to Main Content
engorged tick

The newly launched Johns Hopkins Lyme Disease Clinical Research Center — the first of its kind in the United States — will study the causes and cures of post-treatment Lyme disease syndrome, a debilitating condition that afflicts about 20 percent of the 300,000 people who contract Lyme disease each year. While most people respond to antibiotics, these patients experience extreme fatigue, arthritis-like joint pain, musculoskeletal pain, as well as neurological, cardiac, and cognitive symptoms.

“The syndrome is not fatal, but it is life-altering,” said John Aucott, MD, the center’s founder and director, in a press release.

Aucott has received a grant to examine the impact of the tick-borne illness on the immune systems and long-term health of patients. In this initial controlled study, researchers will seek to understand why post-treatment Lyme disease syndrome persists for months or years in some patients but not in others.

For more on Lyme disease and integrative approaches to treating it, see “Beating Lyme Disease.”

Thoughts to share?

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

City and state are only displayed in our print magazine if your comment is chosen for publication.


More Like This

Beating Lyme
By Pamela Weintraub
For patients with tick-borne diseases, the path to health can be confounding. Combining integrative and conventional approaches may be the best way forward.
Lyme Disease
By Pamela Weintraub
When a mysterious and debilitating illness overtook her and her family, the author struggled to find some answers. What she discovered about Lyme disease — and how little is actually known or agreed upon by the medical experts — is something everyone who goes outdoors should learn.
By Maggie Fazeli Fard
The tick-borne illness, one of the fastest growing diseases in the United States, can be disabling if left untreated.
Back To Top